Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendations
2007

Managing Anemia in Chronic Kidney Disease

Sample size: 1432 publication 10 minutes Evidence: moderate

Author Information

Author(s): Rebecca J Schmidt, Cheryl L Dalton

Primary Institution: West Virginia University Health Sciences Center

Hypothesis

Can treating anemia of chronic kidney disease with erythropoietic agents improve cardiovascular outcomes?

Conclusion

Treating anemia in chronic kidney disease can improve patient outcomes, but careful management is necessary to avoid potential risks.

Supporting Evidence

  • Anemia is linked to increased cardiovascular risk and mortality in chronic kidney disease patients.
  • More than 60% of patients with CKD-related anemia are treated by primary care physicians.
  • Early intervention in anemia management can improve quality of life and reduce hospitalizations.

Takeaway

Anemia is a common problem for people with kidney disease, and treating it can help them feel better and live longer, but doctors need to be careful about how they treat it.

Methodology

This review analyzes observational and randomized studies regarding the treatment of anemia in chronic kidney disease.

Potential Biases

Potential bias in the selection of studies and reporting of outcomes.

Limitations

The review may not cover all recent studies and findings related to anemia treatment in chronic kidney disease.

Participant Demographics

The study includes adults with chronic kidney disease, with a focus on those not requiring dialysis.

Statistical Information

P-Value

0.03

Confidence Interval

95% CI 1.03 to 1.74

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1750-4732-1-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication